Device Trial Radar · NCT05301816
PDN Post Market, Multicenter, Prospective, Global Clinical Study
Last checked: Nov 20, 2026Latest source record: Jun 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
497
Planned (sponsor's estimate)
Start
Jul 5, 2022
Primary completion
Oct 2027
Study completion Oct 2028
Sponsor
- Lead sponsor
- Nevro CorpNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 31, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this post-market study is to evaluate the real-world experience of Nevro's Spinal Cord Stimulation (SCS) therapy in patients with chronic, intractable leg pain due to painful diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study, that will partner diabetes management teams with pain physicians to provide an interdisciplinary treatment regimen for PDN patients. Outcomes will be assessed via standardized assessments.
Conditions
- Diabetic Neuropathy, Painful
Interventions
Spinal Cord Stimulator (SCS)Device
Spinal cord stimulation system (SCS) is an approved system to manage chronic intractable pain of the limbs and/or leg by delivering electrical stimulation using implantable leads and rechargeable implantable pulse generator (IPG) with 16 output channels. The IPG is implanted in a subcutaneous pocket and is capable of stimulating the spinal cord nerves when used with one or two 8-contact percutaneous or paddle leads.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Trial success rate/Responder rateTime frame: 2 weeks
- Patient-reported overall pain reliefTime frame: 12 months
- Leg painTime frame: 12 months
3 more outcomes with a free account
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Neuroversion, Inc.
Anchorage, Alaska
Michigan Pain Specialists
Ann Arbor, Michigan
Henry Ford Health
West Bloomfield, Michigan
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.